Here is how Alcon (ALC) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.

Feb 25 (Reuters) - Alcon on Tuesday forecast 2026 sales growth largely in line with market estimates and guided for a ...

Total30 multifocal for astigmatism, a monthly toric lens for patients with presbyopia, is now available in the U.S., ...

Q4 2025 Management View CEO David Endicott emphasized that "the second half of 2025 and especially the fourth quarter demonstrated the strength and momentum of our business." He highlighted recent ...

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

For discussion purposes, our comments on growth rates are expressed in constant currency. Dave will then return with closing ...

It was business as usual for Alcon, the global eyecare company with manufacturing and research facilities in Berks County.

According to financial terms announced Monday night, Geneva, Switzerland-based Alcon will pay $15.25 for each share of Aerie, a 37% premium to the stock’s closing price on Monday. Aerie went public in ...

Alcon has experienced robust Q1 growth, driven by double-digit growth in vision care, particularly in the contact lens market. The company's strong revenue growth is attributed to successful product ...

Geneva, Switzerland-based Alcon and Orlando, FL-based Lensar have entered a merger agreement through which Alcon intends to acquire Lensar. The acquisition includes the Ally robotic cataract laser ...